Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Tamoxifen|DRUG: Toremifene|DRUG: Anastrozole|DRUG: Letrozole|DRUG: Exemestane
Sponsor: First Hospital of China Medical University
Collaborators: The First Hospital of Jilin University|Second Hospital of Jilin University|Jilin Provincial Tumor Hospital|The Affiliated Zhongshan Hospital of Dalian University|The First Affiliated Hospital of Dalian Medical University|China-Japan Union Hospital, Jilin University|The Second Affiliated Hospital of Dalian Medical University|The Fifth People's Hospital of Shenyang|General Hospital of Benxi Steel & Iron (Group) Co., Ltd|Affiliated Hospital of Hebei University of Engineering|Fourth People's Hospital of Shenyang